Related Experiment Videos
Fatty acid synthase expression in cutaneous melanocytic neoplasms
Payal Kapur1, Dinesh Rakheja, Lonnie C Roy
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9073, USA.
Summary
Fatty acid synthase expression is elevated in malignant melanomas, particularly metastatic types. Congenital nevi also show high expression, possibly due to fetal phenotype similarities.
Area of Science:
- Oncology
- Biochemistry
- Dermatopathology
Background:
- Mammalian fatty acid synthase (FASN) is crucial for synthesizing saturated fatty acids.
- FASN inhibitors are explored as cancer therapeutics due to increased FASN expression in various cancers, including melanoma.
- Elevated FASN expression is observed in malignant melanomas.
Purpose of the Study:
- To investigate immunohistochemical expression of fatty acid synthase in diverse cutaneous melanocytic lesions.
- To correlate FASN expression levels with melanoma type, Clark level, and Breslow thickness.
Main Methods:
- Immunohistochemical analysis of fatty acid synthase expression.
- Evaluation of 155 melanocytic lesions: congenital nevi, compound nevi, Spitz nevi, primary melanomas, and metastatic melanomas.
- Statistical analysis to compare FASN expression across lesion types and melanoma characteristics.
Main Results:
- Fatty acid synthase expression was significantly higher in malignant melanomas compared to conventional and Spitz nevi.
- Metastatic melanomas exhibited the highest FASN expression.
- Primary melanomas showed increased FASN scores with higher Clark levels and Breslow thickness.
- Congenital melanocytic nevi displayed strong FASN expression, comparable to metastatic melanoma.
Conclusions:
- Fatty acid synthase expression is a potential biomarker for melanoma progression and malignancy.
- The high FASN expression in congenital nevi may indicate a persistent fetal phenotype.
- Further research into FASN's role in melanoma pathogenesis and therapeutic targeting is warranted.